SN
GILD icon

Sittner & Nelson’s Gilead Sciences GILD Stock Holding History

Sittner & Nelson’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
8,100
-100
-1% -$13.2K 0.32% 69
2026
Q1 		$1.14M Hold
8,200
– – 0.42% 56
2025
Q4 		$1.25M Sell
8,200
-130
-2% -$15.8K 0.44% 50
2025
Q3 		$925K Hold
8,330
– – 0.34% 54
2025
Q2 		$924K Sell
8,330
-200
-2% -$21.3K 0.37% 53
2025
Q1 		$956K Hold
8,530
– – 0.41% 44
2024
Q4 		$788K Buy
8,530
+9
+0.1% +$810 0.34% 51
2024
Q3 		$714K Buy
8,521
+2,425
+40% +$185K 0.32% 53
2024
Q2 		$418K Sell
6,096
-746
-11% -$49.8K 0.21% 74
2024
Q1 		$501K Buy
6,842
+716
+12% +$55.1K 0.25% 65
2023
Q4 		$496K Sell
6,126
-319
-5% -$24.8K 0.27% 64
2023
Q3 		$483K Buy
6,445
+333
+5% +$25.6K 0.28% 59
2023
Q2 		$471K Sell
6,112
-207
-3% -$16.5K 0.26% 63
2023
Q1 		$524K Sell
6,319
-2,184
-26% -$181K 0.3% 59
2022
Q4 		$730K Sell
8,503
-46
-0.5% -$3.64K 0.45% 46
2022
Q3 		$527K Buy
8,549
+907
+12% +$57.2K 0.35% 53
2022
Q2 		$472K Buy
7,642
+1,879
+33% +$116K 0.31% 58
2022
Q1 		$343K Buy
5,763
+301
+6% +$19.2K 0.2% 79
2021
Q4 		$397K Buy
5,462
+10
+0.2% +$689 0.23% 71
2021
Q3 		$381K Buy
5,452
+950
+21% +$66.7K 0.25% 70
2021
Q2 		$310K Buy
4,502
+300
+7% +$20K 0.22% 69
2021
Q1 		$272K Sell
4,202
-898
-18% -$57.9K 0.2% 72
2020
Q4 		$297K Buy
+5,100
New +$308K 0.27% 69

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sittner & Nelson's GILD Position: Q2 2026 in Review

Sittner & Nelson reduced its Gilead Sciences (GILD) stake by 1.2% in Q2 2026, selling an estimated $13.2K and leaving 8,100 shares worth $1.02M. The position accounts for 0.32% of the portfolio, ranked #69.

Sittner & Nelson first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.25M in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sittner & Nelson held 8,100 shares of Gilead Sciences worth $1.02M as of Q2 2026.
  • Sittner & Nelson sold 100 Gilead Sciences shares in Q2 2026, an estimated $13.2K.
  • Gilead Sciences made up 0.32% of Sittner & Nelson's portfolio in Q2 2026, its #69 holding.
  • Sittner & Nelson first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Sittner & Nelson's Gilead Sciences position peaked at $1.25M in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sittner & Nelson's 13F filing for Q2 2026, filed 7 Aug 2026.